NeuroTrauma Sciences Presents Update on Neuroprotective Compounds NTS-104 and NTS-105 at the 12th Annual Traumatic Brain Injury Conference
/PRNewswire/ -- NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to...
District Of Columbia United States Tomj Parry Susan Pietropaolo Neurotrauma Sciences Chief Science Officer
Source: prnewswire.com